Corbus Pharmaceuticals Holdings (CRBP) EBIT Margin Growth (1y) (2016 - 2021)
Corbus Pharmaceuticals Holdings (CRBP) EBIT Margin Growth (1y) (2016 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -1,651.00 |
| 10 | Corbus Pharmaceuticals Holdings | 127.63 Mn | -35.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | -1.15 Mn |
| Jun 30, 2021 | 108,908.00 |
| Mar 31, 2021 | -68,334.00 |
| Dec 31, 2020 | -130,450.00 |
| Sep 30, 2020 | -179,165.00 |
| Jun 30, 2020 | -1.33 Mn |
| Mar 31, 2020 | -28,951.00 |
| Dec 31, 2019 | 100,790.00 |
| Sep 30, 2019 | 39,662.00 |
| Jun 30, 2019 | 145,772.00 |
| Mar 31, 2019 | -15,817.00 |
| Sep 30, 2018 | -49,206.00 |
| Jun 30, 2018 | 63,033.00 |
| Mar 31, 2018 | -67,230.00 |
| Sep 30, 2017 | -15,533.00 |
| Jun 30, 2017 | -102,530.00 |
| Mar 31, 2017 | 15,193.00 |
| Sep 30, 2016 | 60,460.00 |
| Jun 30, 2016 | 119,828.00 |